stockrow
Friday 6 November 2026
Export MDLN’s income statement to Excel — free account
Medline Inc.
MDLN Healthcare Medical Instruments & Supplies
Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.
- Revenue
- +14.1%
- Free cash flow
- +916.1%
- Total debt
- −23.7%
Quarter to September 2026, against a year earlier
38.99
0.77
−1.94%
Follow MDLN
Alert me
Medline Inc. (MDLN) Gross margin
Medline Inc.'s gross margin over the twelve months to 30 September 2026 was 44.9%, up 18.4 percentage points from fiscal 2025 (26.4%). That is below the Medical Instruments & Supplies industry median of 53.6% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 26.4% | (0.91) |
| FY2024 | 27.4% | 2.02 |
| FY2023 | 25.3% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 24.5% | (4.32) |
| Jun 2026 | 28.8% | 3.78 |
| Mar 2026 | 25.0% | (74.96) |
| Dec 2025 | 100.0% | 72.34 |
| 2 more quarters | Free account |
Gross margin against peers
| Company | Gross margin |
|---|---|
| ISRG Intuitive Surgical, Inc. compare | 67.2% |
| COO The Cooper Companies, Inc. compare | 65.9% |
| RMD ResMed Inc. compare | 61.1% |
| ALC Alcon compare | 56.9% |
| BDX Becton, Dickinson and Company compare | 50.3% |
| MDLN Medline Inc. | 44.9% |
| WST West Pharmaceutical Services, Inc. compare | 37.6% |
| BAX Baxter International Inc. compare | 30.1% |
| SOLV Solventum Corporation compare | 0.00% |
| Medical Instruments & Supplies industry median | 53.6% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on MDLN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Book value per share
- The full statement